Abdalian charles h jr - direct investment history in Coley pharmaceutical group inc

Filed on 2008-01-25 by Abdalian Charles H Jr SEC CIK 1335290 Form 4

Accession 0001181431-08-005476.txt Sec File: edgar/data/1335290/0001181431-08-005476-index.htm

2008-01-04 Abdalian Charles H Jr (CIK 1335290) through Direct (Svp Finance And Cfo)

Invested in Coley Pharmaceutical Group Inc sold 8666 shares remaining shares owned 0

Stock Option Right To Buy Coley Pharmaceutical Group Inc Coly exercise price 1.15 has valueitem expiration due date 2014-11-22 underlying security shares 8666 underlying security title Common Stock - 01 Par Value

f5 these options were cancelled in the merger agreement between pfizer inc. and coley pharmaceutical group, inc. ("coley") in exchange for a cash payment of $59,362, representing the difference between the exercise price of the options and the market value of the underlying coley common stock on the date of the merger ($8 per share).
f1 one quarter of the options vest on the first anniversary of the grant date and the remainder of such options vest monthly thereafter on a pro rata basis over the following three years.


Filed on 2008-01-25 by Abdalian Charles H Jr SEC CIK 1335290 Form 4

Accession 0001181431-08-005476.txt Sec File: edgar/data/1335290/0001181431-08-005476-index.htm

2008-01-04 Abdalian Charles H Jr (CIK 1335290) through Direct (Svp Finance And Cfo)

Invested in Coley Pharmaceutical Group Inc sold 40000 shares remaining shares owned 0

Stock Option Right To Buy Coley Pharmaceutical Group Inc Coly exercise price 3.13 has valueitem expiration due date 2017-09-17 underlying security shares 40000 underlying security title Common Stock - 01 Par Value

f4 these options were cancelled in the merger agreement between pfizer inc. and coley pharmaceutical group, inc. ("coley") in exchange for a cash payment of $194,800, representing the difference between the exercise price of the options and the market value of the underlying coley common stock on the date of the merger ($8 per share).
f1 one quarter of the options vest on the first anniversary of the grant date and the remainder of such options vest monthly thereafter on a pro rata basis over the following three years.


Filed on 2008-01-25 by Abdalian Charles H Jr SEC CIK 1335290 Form 4

Accession 0001181431-08-005476.txt Sec File: edgar/data/1335290/0001181431-08-005476-index.htm

2008-01-04 Abdalian Charles H Jr (CIK 1335290) through Direct (Svp Finance And Cfo)

Invested in Coley Pharmaceutical Group Inc sold 58123 shares remaining shares owned 0

Stock Option Right To Buy Coley Pharmaceutical Group Inc Coly exercise price 1.15 has valueitem expiration due date 2015-01-24 underlying security shares 58123 underlying security title Common Stock - 01 Par Value

f3 these options were cancelled in the merger agreement between pfizer inc. and coley pharmaceutical group, inc. ("coley") in exchange for a cash payment of $398,143, representing the difference between the exercise price of the options and the market value of the underlying coley common stock on the date of the merger ($8 per share).
f1 one quarter of the options vest on the first anniversary of the grant date and the remainder of such options vest monthly thereafter on a pro rata basis over the following three years.


Filed on 2008-01-25 by Abdalian Charles H Jr SEC CIK 1335290 Form 4

Accession 0001181431-08-005476.txt Sec File: edgar/data/1335290/0001181431-08-005476-index.htm

2008-01-04 Abdalian Charles H Jr (CIK 1335290) through Direct (Svp Finance And Cfo)

Invested in Coley Pharmaceutical Group Inc sold 52402 shares remaining shares owned 0

Stock Option Right To Buy Coley Pharmaceutical Group Inc Coly exercise price 1.15 has valueitem expiration due date 2014-03-04 underlying security shares 52402 underlying security title Common Stock - 01 Par Value

f2 these options were cancelled in the merger agreement between pfizer inc. and coley pharmaceutical group, inc. ("coley") in exchange for a cash payment of $358,954, representing the difference between the exercise price of the options and the market value of the underlying coley common stock on the date of the merger ($8 per share).
f1 one quarter of the options vest on the first anniversary of the grant date and the remainder of such options vest monthly thereafter on a pro rata basis over the following three years.


Filed on 2007-09-20 by Abdalian Charles H Jr SEC CIK 1335290 Form 4

Accession 0001181431-07-058298.txt Sec File: edgar/data/1335290/0001181431-07-058298-index.htm

2007-09-18 Abdalian Charles H Jr (CIK 1335290) through Direct (Svp Finance And Cfo)

Invested in Coley Pharmaceutical Group Inc bought 40000 shares at $0 remaining shares owned 40000

Stock Options Right To Buy Coley Pharmaceutical Group Inc Coly exercise date 2008-09-18 exercise price 3.13 has valueitem expiration due date 2017-09-17 underlying security shares 40000 underlying security title Common Stock

f1 the options vest over a four-year period from the date of grant, with one-quarter of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting thereafter in 36 monthly installments.


Filed on 2007-02-21 by Abdalian Charles H Jr SEC CIK 1335290 Form 4

Accession 0001181431-07-013049.txt Sec File: edgar/data/1335290/0001181431-07-013049-index.htm

2007-02-16 Abdalian Charles H Jr (CIK 1335290) through Direct (Svp Finance Cfo)

Invested in Coley Pharmaceutical Group Inc bought 45000 shares at $0 remaining shares owned 45000

Stock Options Right To Buy Coley Pharmaceutical Group Inc Coly exercise date 2008-02-16 exercise price 9.86 has valueitem expiration due date 2017-02-15 underlying security shares 45000 underlying security title Common Stock

f1 the options vest over a four-year period from the date of grant, with one-quarter of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting thereafter in 36 monthly installments.


Filed on 2005-09-29 by Abdalian Charles H Jr SEC CIK 1335290 Form 4

Accession 0001181431-05-053925.txt Sec File: edgar/data/1335290/0001181431-05-053925-index.htm

2005-08-09 Abdalian Charles H Jr (CIK 1335290) through Direct (Svp Finance And Cfo)

Invested in Coley Pharmaceutical Group Inc bought 37117 shares at $0 remaining shares owned 156308

Stock Options Right To Buy Coley Pharmaceutical Group Inc Coly exercise date 2005-08-09 exercise price 16.00 has valueitem expiration due date 2015-08-08 underlying security shares 37117 underlying security title Common Stock

f1 one quarter of the option vests on the first anniversary of the date of grant and the remainder of such option vests monthly thereafter on a pro rata basis over the following three years.


Filed on 2005-08-09 by Abdalian Charles H Jr SEC CIK 1335290 Form 3

Accession 0001181431-05-045665.txt Sec File: edgar/data/1335290/0001181431-05-045665-index.htm

2005-08-08 Abdalian Charles H Jr (CIK 1335290) through Direct (Svp Finance And Cfo)

Invested in Coley Pharmaceutical Group Inc remaining shares owned 119190

Common Stock Coley Pharmaceutical Group Inc Coly